A Study To Investigate The Safety, Tolerability And Blood Levels Of GSK598809

NCT00437840 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

12

Enrollment

INDUSTRY

Sponsor class

Conditions

Substance Dependence

Interventions

DRUG: GSK598809
DRUG: Placebo

Sponsor

GlaxoSmithKline